Eric Lefkofsky Co-founder of Tempus Labs Cares for Cancer Patients

Eric Lefkofsky, the co-founder of Chicago-based Tempus Labs, clearly understands that caring for cancer patients can be a demanding task and that there are many factors upon which to be considered and acted in order to enhance the quality of human life.

Because he is saddened to see that many people are stricken with cancer, he knows that caring for them can be better with the most advanced cancer care services available. The company which he co-founded has forged a good relationship with most of the comprehensive cancer centers of the National Cancer Institute. And, Lefkofsky knows the latest cancer-testing solutions are valuable when caring for patients: sequencing the constitutional (germline) DNA and DNA of patients’ tumors, sequencing liquid biopsy of cell-free circulating tumor DNA, RNA sequencing (RNA-Seq) of tumors, immune system characterization of tumors and patients, and much more.

The company’s commitment to caring for cancer patients has resulted in advances in technology: Tempus Labs uses two biotechnologies, gene therapy and gene editing, for diseases that were once deemed to be untreatable. In 2017, the US Food and Drug Administration (FDA) approved Voretigene neparvovec-rzyl (LuxturnaTM; Spark Therapeutics) as a solution with which to treat a rare, inherited condition of vision loss that may result in blindness. In a specific gene, Voretigene neparvovec-rzyl targets mutations.

From analysis of molecular and therapeutic data, compiled by Tempus Labs’ developers and researchers, to DNA/RNA genomic sequencing services, the company affords physicians the opportunity to provide patients with personalized cancer care.

While Tempus Labs continues its research and development of cancer care solutions for patients, the company has collaborated with most of the nation’s top cancer centers and several academic institutions. Eric Lefkofsky and the company he co-founded are committed to caring for people with cancer and offers important cancer care services a patient needs.

To know more visit @: